Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Lymphedema Advocacy Group
Lobbying Relationship
Bills mentioned
S.497: Lymphedema Treatment Act
Sponsor: Maria Cantwell (D-Wash.)
H.R.930: Lymphedema Treatment Act
Sponsor: Dave Reichert (R-Wash.)
S.2372: Requiring Reporting of Online Terrorist Activity Act
Sponsor: Dianne Feinstein (D-Calif.)
H.R.1608: Lymphedema Treatment Act
Sponsor: Dave Reichert (R-Wash.)
H.R.34: 21st Century Cures Act
Sponsor: Suzanne Bonamici (D-Ore.)
S.870: Creating High-Quality Results and Outcomes Necessary to Improve Chronic...
Sponsor: Orrin G. Hatch (R-Utah)
H.R.1892: Bipartisan Budget Act of 2018
Sponsor: John B. Larson (D-Conn.)
H.R.1625: Consolidated Appropriations Act, 2018
Sponsor: Edward Royce (R-Calif.)
H.R.6157: Department of Defense and Labor, Health and Human Services, and...
Sponsor: Kay Granger (R-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Diane Major | Health Policy Analyst for Senate Republican Policy Committee Health Policy Analyst for Sen. Repub. Policy Com't. |
| Brenda Reese | Conference Coordinator for House Republican Conference |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate